Option Care Health, Inc.
NASDAQ Global SelectRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Option Care Health, Inc. (OPCH) is the nation's largest independent provider of home and alternate site infusion services in the United States, delivering clinical management and customized infusion therapies; anti-infective therapies; heart failure therapies including inotropes; chronic inflammatory disorders such as rheumatoid arthritis, Crohn's disease and ulcerative colitis; immunoglobulin therapies for primary immunodeficiency disorders; bleeding disorder therapies including hemophilia; neurological disorders including multiple sclerosis; and other therapies for nutrition support, bleeding disorders and alpha-1 antitrypsin deficiency; as well as specialty pharmacy services distributing over 50 limited-distribution drugs across its national network of more than 90 full-service pharmacies and 180 ambulatory infusion suites. Founded in 1979 and headquartered in Bannockburn, Illinois, the company serves patients nationwide through partnerships with healthcare providers, hospitals, health systems, pharmaceutical manufacturers and major insurance payers, focusing on acute and chronic conditions to optimize outcomes, reduce readmissions and lower costs with 24/7 support. Recent developments include a strategic partnership with Quince Therapeutics announced in August 2025 to serve as specialty infusion provider for eDSP administration in ataxia-telangiectasia and other indications pending regulatory approval; expansion of its collaboration with WellSky to implement CareTend platform enhancements across over 160 locations for improved pharmacy operations and patient care; and the acquisition of Intramed Plus, a South Carolina-based infusion provider, completed in January 2025 to bolster its regional footprint.
Company News
Are BRZE, SLN, OPCH, RXO Obtaining Fair Deals for their Shareholders?
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Silence Therapeutics plc (Nasdaq – SLN), Option Care Health, Inc. (Nasdaq – OPCH), RXO Inc. (NYSE – RXO), Sangoma Technologies Corporation (Nasdaq – SANG)
Are DSGR, OPCH, PRTH, UTZ Obtaining Fair Deals for their Shareholders?
Are DSGR, OPCH, PRTH, UTZ Obtaining Fair Deals for their Shareholders?
Cencora (NYSE:COR) and Option Care Health (NASDAQ:OPCH) Financial Contrast
OPCH Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Option Care Health to CD&R and McKesson
Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?
Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?
OPCH Investors Have Opportunity to Join Option Care Health, Inc. Fraud Investigation with SBS Law
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Option Care Health, Inc. (NASDAQ: OPCH)
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Option Care Health, Inc. (NASDAQ: OPCH)
Option Care Health Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Option Care Health, Inc. - OPCH
This Option Care Health Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday
Strength Seen in Option Care (OPCH): Can Its 32.7% Jump Turn into More Strength?
Halper Sadeh LLC is Investigating Whether PTC and OPCH are Obtaining Fair Deals for their Shareholders
OPCH SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES OPTION CARE HEALTH, INC.
OPCH SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES OPTION CARE HEALTH, INC.
Option Care Stock Trades Below McKesson's Deal Price — Here's the Spread
Why Option Care Health Stock Skyrocketed on Tuesday
OPCH Stock Alert: Halper Sadeh LLC is Investigating Whether Option Care Health, Inc. is Obtaining a Fair Price for its Shareholders